ABSTRACT Ann Ithibu, Aidspan’s Policy Analyst, tells us why she was motivated to work on health policy and program issues, and her plans for the future.
|
|
| Ann Ithibu |
We also produce articles for the GFO/OFM, some based on our research and others such as those on the Board meeting papers or, for example, the recent articles I wrote on Global Fund grant absorption rates. It is surprising how much work it is to write a relatively short article having sought out the latest data and information. I am currently working on a paper that will also be published as a series of articles documenting countries’ experiences applying for funds and implementing activities under the COVID-19 Resource Mechanism and for that I have been interviewing stakeholders from several African countries.
(Note from Arlette: to be published in July.)
The Policy team also drafts funding applications, as we are entirely donor-supported and always looking for new funding opportunities. We develop the annual workplan and write the Annual Report and the Board briefing papers. Finally, we do a fair amount of design and delivery of capacity-building programs such as the ones for our Supreme Audit Institutions (SAI) project. In this project, we are working with SAIs from across Sub-Saharan Africa, enhancing their role in performing the audit requirements for Global Fund grants which focus not only on finances but the program outcomes as well. Over the next three weeks, we will be holding three three-day five-hour workshops for SAIs in Ethiopia, Lesotho, and Namibia. As anyone who is involved in training knows, this is a huge amount of work and a challenge to keep it fresh and exciting given the online format.
What do I like most? Well, every day brings its own unique experiences and challenges. So, my favourite part of the job is that I am constantly learning new things.
This is when I realized that one cannot work on HIV in isolation without looking at the system within which HIV interventions are delivered. It was the weaknesses of the health system that failed her. These systemic challenges continue to plague our countries nearly ten years later. For example, we have clinics providing antiretroviral medicines but then the health system is not strong enough to manage to supply a consistent flow of medicines ― see our articles in GFO issues #1004 (Kenya facing a shortage of antiretroviral drugs caused by a disagreement between the government and USAID on procurement entity) and #397 (A looming shortage of antiretroviral drugs threatens the wellbeing of Kenyan citizens). So, for me, one of the motivating factors of this job is being able to highlight these issues and get to the root causes of why the system is failing us; and what we can do about it.
One issue that I always come back to is that countries have all this money from the Global Fund but still have problems in fully using it all. We need to better understand why they cannot spend it, because it impacts people’s health and wellbeing.
The situation with the three diseases, health systems and the Global Fund has certainly evolved since I joined Aidspan. Back then, there was a lot of discussion about accountability, and the use of Global Fund monies.
The conversations are now changing with more focus on those receiving the funds ― the programs themselves and the beneficiaries. Countries now have more information available to them, not just from the Global Fund but many other sources; and, as a result, stakeholders are more empowered, more knowledgeable and more aware of examples and lessons learnt from other countries. But information in itself is not enough. They have to be able to translate it into dealing with the challenges of grant implementation.
Now, as Aidspan, we see even greater challenges regarding two related issues: (i) the health system, which is cross-cutting and the foundation of the disease response, whose success depends on the strength of the health system itself; and (ii) what is happening on the country level. We had still not finished ‘unpacking’ the issues at the country level that are crucial for successful responses to the three diseases when the new challenge of COVID-19 arrived. As an example, procurement and supply management is a problem for virtually all countries. And with a pandemic that requires a quick emergency response, we see that procurement of health products such as personal protective equipment may be made in 2020, but the country only receives the good in June 2021: and it is not a question of the funds being unavailable, it is an issue of the system’s inability to deal quickly and efficiently with the procurement request. This is just one of many bottlenecks countries have to address. But probably one of the most important.
No comments yet. Be the first to comment!